Healthcare analytics company, Apixio, is poised to grow revenue, staff, and product offerings by the end of 2020.
FREMONT, CA: Apixio, the healthcare AI analytics company, anticipates its revenue in 2020 to grow by more than 50 percent compared with last year. This growth will demonstrate the continued strong demand for the company's AI-powered data analytics solutions among the organizations managing government-sponsored health plans.
Apixio plans to expand its staff and product offerings by the end of 2020 to broaden its capabilities to support value-based healthcare payment and delivery with actionable intelligence.
“Now more than ever, we need reliable data analytics solutions to improve healthcare delivery and spot critical trends for improved efficiency and patient outcomes,” said Apixio CEO Dr. Darren Schulte. “Apixio is able to effectively use AI to mine large volumes of digital data for high quality insights that can improve care delivery and reimbursement.”
Apixio is also looking forward to launch three additional solutions related to electronic data acquisition and patient encounter guidance by the end of the year. These solutions will help streamline the patient data collection and empower physicians with better insights to secure optimal health outcomes.
Apixio desires to expand its employee strength by 25 percent this year, including filling vacancies in consumer operations, data science, software engineering, customer operations, marketing, and finance. To support the company's growth, Apixio recently appointed Sachin Patel as President and CFO, expanding on his previous role.
The Apixio solution is outperforming the industry averages in all categories of customer experience and customer perception.
“We’re extremely pleased with the momentum we’ve seen over the last year, and our trajectory shows no signs of slowing down,” Schulte said. “Healthcare data analytics is an increasingly urgent need for healthcare organizations, especially as care delivery becomes virtual. Apixio has been proven to deliver reliable results that exceed expectations,” he added.